10-K/A

BIOTIME 10KA 12-31-2010

Company: Lineage Cell Therapeutics, Inc.
Filed: March 17, 2011
Period of Report: December 31, 2010
Accession Number: 0001140361-11-017300

View Document ↗ View on SEC.gov ↗